Juno Therapeutics, a heavily funded biotech company with a novel approach to fighting cancer, filed plans for an initial public offering today — seeking to raise at least $150 million… Read More
Juno Therapeutics, a new Seattle startup that’s trying to eliminate cancer from the human body, raised a hefty $120 million series A round last month. Now, it is receiving even… Read More
One big problem with existing cancer therapies available today like chemotherapy and radiation is the collateral damage. While some medicine can completely kill cancer, it also may destroy healthy, normal… Read More
In one of the largest series A venture capital deals this year in the biotechnology sector, Seattle-based Juno Therapeutics has landed $120 million in startup financing in a deal led… Read More